Human T Cell Lymphotropic Virus Type 1 (htlv 1) - Infectious Diseases

Relevant Publications

Imbalanced IL10/TGF-β production by regulatory T-lymphocytes in patients with HTLV-1-associated myelopathy/ tropical spastic paraparesis.

Issue Release: 2024

Novel insights into human T-lymphotropic virus type-1 (HTLV-1) pathogenesis-host interactions in the manifestation of HTLV-1-associated myelopathy/tropical spastic paraparesis.

Issue Release: 2024

HTLV-1 vaccination Landscape: Current developments and challenges.

Issue Release: 2024

Large-Scale Whole-Genome Analysis of HTLV-1-Associated Myelopathy Identified Hereditary Spastic Paraplegias.

Issue Release: 2024

Modified Prophylactic Donor Lymphocyte Infusion (DLI) in an Adult T Cell Lymphoma/Leukemia (ATLL) Patient-Modality of Relapse Prevention.

Issue Release: 2024

Effects of HTLV-1 on leukocyte trafficking and migration in ACs compared to healthy individuals.

Issue Release: 2024

Novel approaches for HTLV-1 therapy: innovative applications of CRISPR-Cas9.

Issue Release: 2024

ReporType: A Flexible Bioinformatics Tool for Targeted Loci Screening and Typing of Infectious Agents.

Issue Release: 2024

How do socioeconomic determinants of health affect the likelihood of living with HTLV-1 globally? A systematic review with meta-analysis.

Issue Release: 2024

Heterogeneous nuclear ribonucleoprotein K promotes cap-independent translation initiation of retroviral mRNAs.

Issue Release: 2024

Role of Interleukin-17 cytokine family in human T-cell lymphotropic virus type 1 (HTLV-1) infection and associated diseases.

Issue Release: 2024

Analysis of the Main Checkpoints of the JNK-MAPK Pathway in HTLV-1-Associated Leukemia/Lymphoma via Boolean Network Simulation.

Issue Release: 2024

Development of Innate-Immune-Cell-Based Immunotherapy for Adult T-Cell Leukemia-Lymphoma.

Issue Release: 2024

Varied presentations of primary cutaneous lymphoma: A case series from a tertiary care center in South India.

Issue Release: 2024

Determination of molecular epidemiologic pattern of human T-lymphotropic virus type 1 (HTLV-1) in Alborz province, Iran.

Issue Release: 2024

HTLV-1 reverse transcriptase homology model provides structural basis for sensitivity to existing nucleoside/nucleotide reverse transcriptase inhibitors.

Issue Release: 2024

Cell Culture Evaluation Hints Widely Available HIV Drugs Are Primed for Success if Repurposed for HTLV-1 Prevention.

Issue Release: 2024

High level of genomic divergence in orf-I p12 and hbz genes of HTLV-1 subtype-C in Central Australia.

Issue Release: 2024

High HTLV-1 Proviral Load Predates and Predicts HTLV-1-Associated Disease: Literature Review and the London Experience.

Issue Release: 2024

Higher expression of BRCA1, and CHUK and lower expression of NFKBIA, ESR1, PIK3R1, and PPARG in HAM/TSP compared to ATLL, a diverse pathological consequence.

Issue Release: 2024

How Do Hand Sanitizers Work?

What are the Potential Complications of Strep Throat?

What is Zika Virus?

What is Ebola?

How Does the Global Fund Work?

What is the global impact of Flaviviridae infections?

How is Drug Toxicity Measured?

What are the Benefits of Gene Therapy and Immunotherapy?

Are There Metabolic Pathway Differences Between Pathogens and Hosts?

What is the Treatment for Dengue Hemorrhagic Fever?

Partnered Content Networks

Relevant Topics